Gynoglycosides from Gynostemma pentaphyllum

The State Food and Drug Administration has only approved two pharmaceutical companies to produce gypenosides, among which Ankang Chia Tai Pharmacetucial Co., Ltd. is one of them. The fixed-point purchase of Gynostemma pentaphyllum ensures the high-quality source of raw materials, and the independent extraction and internal control standards higher than Pharmacopoeia ensure the qualified raw material quality. Ankang Chia Tai Pharmacetucial Co., Ltd. and Chinese Academy of Military Medical Sciences cooperated deeply to study and calibrate the components of Gynostemma pentaphyllum saponins. The Chinese Academy of Inspection has accepted the application for component calibration, and the reference substance will be based on the calibration and detection of Gynostemma pentaphyllum saponins raw materials of our company.